|
|
|
|
|
|
  
|
|
|
|
members
Rachel J. Buchsbaum, MD
Principal Investigator
Rachel J. Buchsbaum
AB, Harvard University, Cambridge, MA
MD, Cornell University Medical College, New York, NY
Residency in Internal Medicine, Beth Israel Hospital, Boston, MA
Fellowship in Hematology and Oncology, Tufts Medical Center, Boston, MA
Post-doctoral Training, Tufts University School of Medicine, Boston, MA
I became interested in cancer research during medical school and residency. During my early fellowship training in Hematology and Oncology I explored the biology of B and T lymphocytes and the role of cytotoxic T lymphocytes in murine models of EBV-associated lymphoproliferative disease. I subsequently became interested in using the molecular biology of signal transduction to investigate pathways underlying cancer cell invasion and metastasis. My laboratory joined the Molecular Oncology Research Institute in the fall of 2003.
|
Soumitra Rajagopal, PhD
Postdoctoral Fellow
Soumitra Rajagopal
BSc, Microbiology/Biochemistry, SIES College of Arts, Science and Commerce,
Bombay, India
MSc, Medical Biochemistry, T.N. Medical College, University of Bombay, India
MS, Biochemistry, University of
Nebraska, Lincoln, Nebraska
PhD, Microbial Physiology/Microbial Genetics, University of Nebraska, Lincoln,
Nebraska
I am studying the effect of scaffold proteins on Tiam1
activation of Rac pathways and their role in cell growth, survival, and
motility. To do this I am developing
FRET-based assays and using knock-out models in both normal and transformed
cells.
|
|
|
Kun Xu, PhD
Research Associate
Kun Xu
BS, Genetics,
Heilongjiang
Agricultural
University
,
China
MS, Veterinary Medicine, Western
College of Veterinary Medicine
,
Canada
PhD, Biochemistry and Molecular Biology,
University
of
Maine
,
Orono
,
Maine
I am studying a novel pathway we have identified involving Tiam1 and cell cycle
regulation. My project is to
determine the functional significance of this pathway in breast cancer cells.
|
|
|
|
Return to Top
Please send feedback to the MORI Administrator
|
|
|
|
©Copyright 2004, Molecular Oncology Research Institute, All Rights Reserved
|
|